Establishment Labs Holdings (ESTA) Cash from Investing Activities (2017 - 2026)
Establishment Labs Holdings' (ESTA) quarterly Cash from Investing Activities came in at -$2.0 million in Q1 2026, down 46.71% year-on-year from -$3.7 million in Q1 2025, and down 18.0% quarter-over-quarter from -$1.7 million in Q4 2025.
Establishment Labs Holdings (ESTA) Cash from Investing Activities (2017 - 2026) Analysis & Trends
Establishment Labs Holdings' Cash from Investing Activities history runs 10 years deep, the most recent figure standing at -$2.0 million for Q1 2026.
- On a quarterly basis, Cash from Investing Activities fell 46.71% year-over-year to -$2.0 million in Q1 2026; TTM through Mar 2026 was -$7.7 million, a 25.86% increase from a year earlier, with the FY2025 full-year figure at -$7.0 million, up 54.98% from the prior year.
- Cash from Investing Activities slipped to -$2.0 million in Q1 2026 per ESTA's latest filing, from -$1.7 million in the prior quarter.
- Across five years, Cash from Investing Activities topped out at -$1.3 million in Q1 2025 and bottomed at -$13.8 million in Q2 2022.
- The 5-year median for Cash from Investing Activities is -$4.4 million (2024), against an average of -$4.9 million.
- Across the five-year window, Cash from Investing Activities slumped 1380.6% in 2022 and jumped 79.84% in 2025, its largest moves.
- Year by year, Cash from Investing Activities stood at -$10.4 million in 2022, then jumped by 55.7% to -$4.6 million in 2023, then surged by 60.63% to -$1.8 million in 2024, then rose by 8.69% to -$1.7 million in 2025, then slipped by 18.0% to -$2.0 million in 2026.
- Per Business Quant, the three latest ESTA Cash from Investing Activities figures stand at -$2.0 million (Q1 2026), -$1.7 million (Q4 2025), and -$2.0 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | -20.32 Bn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | -185.00 Mn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | -917.00 Mn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | -591.00 Mn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | -92.80 Mn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | -298.50 Mn |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | -2.50 Bn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | -475.32 Mn |
| 10 | Establishment Labs Holdings | 2.75 Bn | 2.68 Bn | 42.34 Mn | -1.96 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.96 Mn |
| Mar 31, 2026 | -1.96 Mn |
| Dec 31, 2025 | -1.66 Mn |
| Dec 31, 2025 | -1.66 Mn |
| Sep 30, 2025 | -1.96 Mn |
| Sep 30, 2025 | -1.96 Mn |
| Jun 30, 2025 | -2.07 Mn |
| Jun 30, 2025 | -2.07 Mn |
| Mar 31, 2025 | -1.34 Mn |
| Mar 31, 2025 | -1.34 Mn |
| Dec 31, 2024 | -1.82 Mn |
| Dec 31, 2024 | -1.82 Mn |
| Sep 30, 2024 | -2.77 Mn |
| Sep 30, 2024 | -2.77 Mn |
| Jun 30, 2024 | -4.40 Mn |
| Jun 30, 2024 | -4.40 Mn |
| Mar 31, 2024 | -6.63 Mn |
| Mar 31, 2024 | -6.63 Mn |
| Dec 31, 2023 | -4.62 Mn |
| Dec 31, 2023 | -4.62 Mn |